Study limitation: The study does not report clinical outcomes (e.g., hospitalizations, mortality) linked to treatment gaps, limiting direct patient-harm quantification | ReachRx
Formulary-Related Insurance Denials of Single-Source Branded Drugs in the United States
Study limitation reported by the research below: “The study does not report clinical outcomes (e.g., hospitalizations, mortality) linked to treatment gaps, limiting direct patient-harm quantification.”
